Our share price analysis, data and how-to-buy guides cover significant market movements in the most popular UK shares in the FTSE 100, US stocks in the DJIA, commodities, indices, and currency pairs. They are designed to help you make more informed decisions about what to invest in, what to trade, and when to execute currency transactions.
Search For UK & US Share Prices & Data
Featured Broker For Dealing Shares
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
75.3% of retail investor accounts lose money when trading CFDs with this provider
64% of retail investor accounts lose money when trading CFDs with this provider
Popular Share Prices
Recent Share Price Analysis
JP Morgan’s Record Heights: Exploring the Potential Peak of a Banking Titan
JP Morgan (NYSE:JPM) is widely regarded as one of the best banks in the world. Founded in 1871, it has been dominating the banking industry for a long time. Recently, JPM stock has been a great investment. Earlier this month, it hit new all-time highs. The question is – how high can it go? How high
Intel’s Surge and Future Prospects: Analyzing the Semiconductor Giant’s Path to 2025
Intel (NASDAQ:INTC) shares have had a great run recently. Over the last year, they’ve climbed from $28 to $43 as demand for semiconductors – and interest in artificial intelligence (AI) investing – has picked up. Here, we look at what Intel shares could be worth in 2025. Let’s dive in. What will Intel shares be
Merck’s Momentum: Analysing the Potential Upswing in this Pharma Giant’s Stock Price
Merck & Co (NYSE:MRK) shares are in a strong uptrend right now. Over the last three months, they have climbed from around $104 to $127. Here, I’m going to look at analysts’ target price for Merck & Co. Can the pharma stock keep rising? What’s driving the Merck share price? Before I reveal the target
IBM’s AI-Powered Surge: Is Now the Time to Sell or Hold IBM Shares?
IBM (NYSE:IBM) stock has been on a tear recently. Over the last year, IBM’s stock price has risen from around $135 to $183 – a gain of approximately 36%. Is it time to sell the stock? Or should investors hold on for further gains? Let’s discuss. IBM is an AI play IBM is having a
Coca-Cola’s Stock Journey: From Buffett’s Bet to Growth Giant, Is KO Still a Buy at $60?
Coca Cola (NYSE:KO) is one of the best-known brands in the world. The red-and-white label is iconic and ubiquitous; the fizzy drinks are sold in 200 countries. For many years, Coca-Cola was seen as a boring stock. Its magic drink formula was virtually unrecognised by the market – until Warren Buffett bought a half-a-billion stake
Steady Journey: Unpacking Travelers Companies Inc’s Market Position and Growth Trajectory
Travelers Companies Inc (TRV) is an insurance business that offers property, casualty and surety products, across the US and in select international markets. With a $48.0 billion market cap, it’s far from the biggest stock in the sector, however, it compares favourably enough with the likes of Allstate and AIG. Travelers has annual sales of